Clinical trial
Evaluation of Efficacy of Intravitreal Bevacizumab Retreatments
NCT00406744 is registered in ClinicalTrials.gov with Asociación para Evitar la Ceguera en México as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Efficacy of Intravitreal Bevacizumab Retreatments
- Lead sponsor
- Asociación para Evitar la Ceguera en México
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- May 31, 2006
- Completion date
- November 30, 2006
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
age related macular degeneration, choroidal neovascularization